Skip to main content

Peer Review reports

From: Cyclophosphamide induced early remission and was superior to rituximab in idiopathic membranous nephropathy patients with high anti-PLA2R antibody levels

Original Submission
21 Nov 2022 Submitted Original manuscript
27 Mar 2023 Reviewed Reviewer Report
15 Apr 2023 Reviewed Reviewer Report
15 Jun 2023 Reviewed Reviewer Report
18 Jul 2023 Author responded Author comments - Bing Dai
Resubmission - Version 2
18 Jul 2023 Submitted Manuscript version 2
26 Jul 2023 Author responded Author comments - Bing Dai
Resubmission - Version 3
26 Jul 2023 Submitted Manuscript version 3
3 Aug 2023 Reviewed Reviewer Report
20 Aug 2023 Reviewed Reviewer Report
21 Aug 2023 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
22 Aug 2023 Editorially accepted
22 Sep 2023 Article published 10.1186/s12882-023-03307-x

You can find further information about peer review here.

Back to article page